Measuring Endothelial Function
Yes, endothelial function can be measured using flow-mediated dilation (FMD) of the brachial artery, which is the gold-standard non-invasive technique recommended by the American College of Cardiology. 1, 2
Primary Method: Flow-Mediated Dilation (FMD)
Equipment Requirements
- Use a high-resolution ultrasound system with a linear array transducer of 7–12 MHz frequency to visualize the brachial artery with adequate resolution 2
- A standard blood pressure cuff capable of inflating ≥50 mm Hg above systolic pressure is required for arterial occlusion 2
- ECG gating should be employed to synchronize measurements with the cardiac cycle and improve timing accuracy 2
Patient Preparation
- Patients must fast for 4–6 hours and avoid caffeine, high-fat foods, vitamin C, and tobacco for the same period before testing 2
- Position the patient supine with the arm comfortably supported at heart level 2
- Note that menstrual cycle phase may affect results in women 2
Step-by-Step Protocol
1. Baseline Imaging
- Position the ultrasound probe longitudinally 5–10 cm proximal to the antecubital fossa to obtain clear anterior and posterior intimal interfaces 2
- Record the baseline brachial artery diameter at end-diastole (aligned with the R-wave on ECG) to avoid confounding from vessel compliance changes 2
- Acquire baseline blood flow velocity with pulsed Doppler immediately after the diameter measurement 2
2. Cuff Occlusion (Creating the Hyperemic Stimulus)
- Inflate the cuff to at least 50 mm Hg above systolic pressure for exactly 5 minutes 1, 2
- This 5-minute duration yields results comparable to 10-minute inflations while being better tolerated by patients 1, 2
- The cuff can be placed either on the upper arm or forearm, with important trade-offs 1, 2:
3. Post-Deflation Assessment
- Begin continuous ultrasound recording 30 seconds before cuff release and continue for 2 minutes after deflation to capture the full dilation curve 1, 2
- Obtain a pulsed Doppler signal within 15 seconds of cuff release to quantify the hyperemic flow velocity peak 1, 2
- Peak arterial dilation typically occurs around 60 seconds after cuff release (or 45–60 seconds after peak hyperemic flow) 1, 2
Measurement Standards
- Measure arterial diameter at the lumen-intima interface on both the near and far walls using a perpendicular insonation angle 1, 2
- Perform measurements along a longitudinal arterial segment rather than a single point to reduce variability 1, 2
- Express FMD as the percent change from baseline diameter: [(post-stimulus diameter – baseline diameter) / baseline diameter] × 100% 2
- Report baseline diameter, absolute change, and percent change to account for baseline-diameter effects 2
Complementary Test: Endothelium-Independent Vasodilation
Nitroglycerin Test Protocol
- Wait at least 10 minutes after the FMD assessment for the artery to return to baseline before performing this test 1, 2
- Administer 0.4 mg sublingual nitroglycerin (spray or tablet) to evaluate smooth-muscle function independent of endothelial nitric oxide production 1, 2
- Record continuous vasodilation for 3–4 minutes after nitroglycerin administration; peak dilation occurs within this window 1, 2
- Contraindications include clinically significant bradycardia or hypotension 1, 2
Technical Limitations and Caveats
Vessel Size Constraints
- **Arteries with a lumen diameter <2.5 mm are difficult to measure accurately**, whereas vessels >5.0 mm show less perceptible vasodilation 1, 2
- The FMD technique can be applied to radial, axillary, and superficial femoral arteries, but operator expertise is essential 1, 2
Common Pitfalls to Avoid
- Inconsistent hyperemic flow stimulus will compromise reproducibility—always document peak hyperemic velocity 2
- Unaccounted changes in baseline diameter between measurements can confound results 2
- Poor image quality caused by inadequate transducer positioning or patient movement compromises measurement reliability 1, 2
- Measurements taken at end-systole rather than end-diastole introduce additional variability due to vessel compliance changes 2
- Failure to control confounding factors (diet, medications, time of day) can all compromise FMD results 2
Alternative Methods
Peripheral Arterial Tonometry (PAT)
- PAT evaluates pulse wave amplitude in the fingertips during reactive hyperemia, which is linked to endothelial function in the microcirculation 3
- Unlike FMD, which directly measures large-conduit artery dilation, PAT measures flow response hyperemia related to small artery and microcirculatory endothelial function 3
- This technique is mostly used for investigation of the functional capability of the microcirculation rather than conduit arteries 3
Low-Flow-Mediated Constriction (L-FMC)
- L-FMC quantifies the decrease in forearm conduit artery diameter during cuff occlusion (before release), providing complementary information to FMD 3
- The L-FMC response is not based on nitric oxide availability but may be mediated by other substances, providing a coordinated effect of vasodilation and its inhibition 3
Clinical Utility and Interpretation
Normal Values and Reproducibility
- Acceptable reproducibility is a mean difference of 2–3% in FMD over time, with baseline vasodilation typically around 10% in healthy subjects 2
- Approximately 70% of the dilation observed at 1 minute is attributable to nitric oxide synthesis 2
Clinical Applications
- FMD is useful for showing the relationship between atherosclerosis and endothelial function, mechanisms of endothelial dysfunction, and clinical implications including effects of interventions and cardiovascular events 4, 5
- Endothelial dysfunction assessed by FMD has been shown to be a marker for risk of cardiovascular events in high-risk groups 6
- FMD must be performed by qualified and experienced medical staff to ensure reliability 4